GlaxoSmithKline CEO-to-be Emma Walmsley will leave a chair vacant at the top of its key consumer health JV, and stepping in to take it is Brian McNamara, a…

Just two years after working on a massive dual-focus manufacturing facility in Asia, AbbVie says the first phase is good to go.

Kyowa Hakko Kirin is rolling out the psoriasis med brodalumab this week in Japan, its first world market, but it faces a tough road ahead.

It’s Day 2 of the 7-day district court hearing over the patent protection on Teva’s 40-mg Copaxone, and so far, things aren’t looking great for the drugmaker.

Plenty of drugmakers, including Shire and J&J, market ADHD drugs for children. But those drugs may not help kids do their homework or get better grades, a…

You know that old saw about every med school graduate winning the “Doctor” title? Something similar could apply to Sarepta’s newly approved Duchenne muscular…

A dozen specialty pharmacies made it to this year’s Inc. magazine list of fastest growing private companies in the U.S., including one in the top 10.

Pfizer’s vaccines business has enjoyed tremendous growth, thanks to the superstar pneumococcal blocker Prevnar 13. But that growth could be tough to sustain,…